Abbott Laboratories
105.23USD
-0.2900 (-0.27%)
Computing valuation metrics…
Valuation
P/E (TTM)
29.01x
P/E (Forward)
17.35x
EV/EBITDA
22.90x
EV/Revenue
4.66x
P/S (TTM)
4.03x
P/B
3.50x
FCF Yield
4.05%
Dividend Yield
2.39%
Gross Margin
56.26%
Operating Margin
17.07%
Net Margin
13.91%
Peer Comparison — Medical Devices
| Company | Mkt Cap | P/E | EV/EBITDA | FCF Yield | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|
| ABTAbbott Laboratories | $182.09B | 29.01x | 22.90x | 4.05% | 7.78% | 2.39% |
| MDTMedtronic plc | $118.18B | 22.76x | 13.49x | 4.58% | 13.70% | 3.06% |
Subject metrics from SEC filings where available; peer metrics from cached market data.
| $106.03B |
| 28.68x |
| 17.39x |
| 3.87% |
| 9.40% |
| 1.16% |
| BSXBoston Scientific Corporation | $65.19B | 18.21x | 13.57x | 3.76% | 7.50% | — |
| EWEdwards Lifesciences Corporation | $49.99B | 51.62x | 24.23x | 2.47% | 13.60% | — |
| DXCMDexCom, Inc. | $31.90B | 33.41x | 22.34x | 3.20% | 13.10% | — |
| GEHCGE HealthCare Technologies Inc. | $30.16B | 15.39x | 10.82x | 5.22% | 5.80% | 0.20% |
| STESTERIS plc | $21.30B | 26.70x | 13.94x | 3.75% | 7.30% | 1.15% |
| ZBHZimmer Biomet Holdings, Inc. | $18.05B | 22.96x | 9.83x | 6.05% | 4.80% | 1.02% |